247 related articles for article (PubMed ID: 8740453)
1. The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits.
de Carvalho LP; Bochet P; Rossier J
Neurochem Int; 1996 Apr; 28(4):445-52. PubMed ID: 8740453
[TBL] [Abstract][Full Text] [Related]
2. Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors.
Zhong J; Gribkoff VK; Molinoff PB
Mol Pharmacol; 1996 Sep; 50(3):631-8. PubMed ID: 8794904
[TBL] [Abstract][Full Text] [Related]
3. NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology.
Monaghan DT; Larsen H
J Pharmacol Exp Ther; 1997 Feb; 280(2):614-20. PubMed ID: 9023271
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes.
Buller AL; Monaghan DT
Eur J Pharmacol; 1997 Feb; 320(1):87-94. PubMed ID: 9049607
[TBL] [Abstract][Full Text] [Related]
5. The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition.
Buller AL; Larson HC; Schneider BE; Beaton JA; Morrisett RA; Monaghan DT
J Neurosci; 1994 Sep; 14(9):5471-84. PubMed ID: 7916045
[TBL] [Abstract][Full Text] [Related]
6. Effects of acute and chronic ethanol exposure on heteromeric N-methyl-D-aspartate receptors expressed in HEK 293 cells.
Blevins T; Mirshahi T; Chandler LJ; Woodward JJ
J Neurochem; 1997 Dec; 69(6):2345-54. PubMed ID: 9375665
[TBL] [Abstract][Full Text] [Related]
7. Glycine modulates ethanol inhibition of heteromeric N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
Buller AL; Larson HC; Morrisett RA; Monaghan DT
Mol Pharmacol; 1995 Oct; 48(4):717-23. PubMed ID: 7476899
[TBL] [Abstract][Full Text] [Related]
8. Evidence that functional glutamate receptors are not expressed on rat or human cerebromicrovascular endothelial cells.
Morley P; Small DL; Murray CL; Mealing GA; Poulter MO; Durkin JP; Stanimirovic DB
J Cereb Blood Flow Metab; 1998 Apr; 18(4):396-406. PubMed ID: 9538905
[TBL] [Abstract][Full Text] [Related]
9. Mg2+ and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes.
Wrighton DC; Baker EJ; Chen PE; Wyllie DJ
J Physiol; 2008 Jan; 586(1):211-25. PubMed ID: 17962329
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids.
Malayev A; Gibbs TT; Farb DH
Br J Pharmacol; 2002 Feb; 135(4):901-9. PubMed ID: 11861317
[TBL] [Abstract][Full Text] [Related]
11. Excitant activity of methyl derivatives of quinolinic acid on rat cortical neurones.
Stone TW
Br J Pharmacol; 1984 Jan; 81(1):175-81. PubMed ID: 6546701
[TBL] [Abstract][Full Text] [Related]
12. Spermine potentiation of recombinant N-methyl-D-aspartate receptors is affected by subunit composition.
Zhang L; Zheng X; Paupard MC; Wang AP; Santchi L; Friedman LK; Zukin RS; Bennett MV
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10883-7. PubMed ID: 7971977
[TBL] [Abstract][Full Text] [Related]
13. Preferential co-assembly of recombinant NMDA receptors composed of three different subunits.
Wafford KA; Bain CJ; Le Bourdelles B; Whiting PJ; Kemp JA
Neuroreport; 1993 Sep; 4(12):1347-9. PubMed ID: 7903167
[TBL] [Abstract][Full Text] [Related]
14. Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors.
Vicini S; Wang JF; Li JH; Zhu WJ; Wang YH; Luo JH; Wolfe BB; Grayson DR
J Neurophysiol; 1998 Feb; 79(2):555-66. PubMed ID: 9463421
[TBL] [Abstract][Full Text] [Related]
15. NMDA and non-NMDA receptor-mediated excitotoxicity are potentiated in cultured striatal neurons by prior chronic depolarization.
Chen Q; Surmeier DJ; Reiner A
Exp Neurol; 1999 Sep; 159(1):283-96. PubMed ID: 10486197
[TBL] [Abstract][Full Text] [Related]
16. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
Williams K
Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning, functional expression, and pharmacological characterization of an N-methyl-D-aspartate receptor subunit from human brain.
Planells-Cases R; Sun W; Ferrer-Montiel AV; Montal M
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5057-61. PubMed ID: 7685113
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
Priestley T; Laughton P; Myers J; Le Bourdellés B; Kerby J; Whiting PJ
Mol Pharmacol; 1995 Nov; 48(5):841-8. PubMed ID: 7476914
[TBL] [Abstract][Full Text] [Related]
19. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
[TBL] [Abstract][Full Text] [Related]
20. Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition.
Laurie DJ; Seeburg PH
Eur J Pharmacol; 1994 Aug; 268(3):335-45. PubMed ID: 7528680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
